Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15.
Pharmacoecon Open
; 7(6): 863-875, 2023 Nov.
Article
in En
| MEDLINE
| ID: mdl-37731145
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Aspects:
Patient_preference
Language:
En
Journal:
Pharmacoecon Open
Year:
2023
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
Switzerland